Abstract

BackgroundCollecting (Bellini) duct carcinoma (CDC) is a highly malignant and rare kidney tumor. We report our 12-year experience with CDC and the results of a retrospective analysis of patients and tumor characteristics, clinical manifestations, and imaging features by computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET)/CT.MethodsRetrospective examination of tumors between January 2007 and December 2019 identified 13 cases of CDC from three medical centers in northern China. All 13 patients underwent CT scan, among which eight underwent dynamic enhanced CT scan, two underwent PET/CT scan, and one underwent magnetic resonance cholangiopancreatography (MRCP) examination. The lesions were divided into nephritis type and mass type according to the morphology of the tumors.ResultsThe study group included ten men and three women with an average age of 64.23 ± 10.74 years. The clinical manifestations were gross hematuria, flank pain, and waist discomfort. The mean tumor size was 8.48 ± 2.48 cm. Of the 13 cases, six (46.2%) were cortical-medullary involved type and seven (53.8%) were cortex–medullary–pelvis involved type. Eleven (84.6%) cases were nephritis type and two (15.4%) were mass type. The lesions appeared solid or complex solid and cystic on CT and MRI. The parenchymal area of the tumors showed isodensity or slightly higher density on unenhanced CT scan in the 13 cases. PET/CT in two cases showed increased radioactivity intake. Evidence of intra-abdominal metastatic disease was present on CT in nine (69.2%) cases.ConclusionsThe imaging characteristics of CDC differ from those of other renal cell carcinomas. In renal tumors located in the junction zone of the renal cortex and medulla that show unclear borders, slight enhancement, and metastases in the early stage, a diagnosis of CDC needs to be considered. PET/CT provides crucial information for the diagnosis of CDC, as well as for designing treatment strategies including surgery.

Highlights

  • Collecting (Bellini) duct carcinoma (CDC) is a highly malignant and rare kidney tumor

  • Collecting duct carcinoma (CDC) is a highly malignant kidney tumor which rarely occurs in clinical practice, accounting for 1–2% of renal cell carcinomas

  • Unlike renal cell carcinoma (RCC), CDC arises from the renal medulla of Bellini tubes

Read more

Summary

Introduction

Collecting (Bellini) duct carcinoma (CDC) is a highly malignant and rare kidney tumor. We report our 12-year experience with CDC and the results of a retrospective analysis of patients and tumor characteristics, clinical manifestations, and imaging features by computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET)/CT. Collecting duct carcinoma (CDC) is a highly malignant kidney tumor which rarely occurs in clinical practice, accounting for 1–2% of renal cell carcinomas. Unlike renal cell carcinoma (RCC), CDC arises from the renal medulla of Bellini tubes. The biological behavior and the morphological and functional manifestations of CDC have unique characteristics, and CDC differs significantly from other types of renal carcinoma [3,4,5,6]. We performed a literature review and retrospectively analyzed the imaging findings of 13 renal CDCs to provide insight into the imaging features of the disease

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call